Alcresta Therapeutics, Inc.
FDA Regulatory Profile
Alcresta Therapeutics, Inc. appears in FDA public data with 0 recalls, 7 510(k) clearances, 3 FDA inspections, and 0 compliance actions on record. Its most recent 510(k) clearance was granted on Apr 17, 2025.
Summary
- Total Recalls
- 0
- 510(k) Clearances
- 7
- Inspections
- 3
- Compliance Actions
- 0
Recent 510(k) Clearances
| K-Number | Device | Date |
|---|
| K250499 | RELiZORB (100300/100301) | Apr 17, 2025 |
| K243284 | RELiZORB (100300/ 100301) | Jan 15, 2025 |
| K232784 | RELiZORB® | Dec 21, 2023 |
| K231156 | Enzyme Packed Cartridge - RELiZORB | Aug 30, 2023 |
| K191379 | RELiZORB | Dec 4, 2019 |
| K163057 | Relizorb | Jul 12, 2017 |
| K161247 | Relizorb | Jun 30, 2016 |